Home > Financial Ratios > DR REDDYS LABORATORIES

DR REDDYS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DR REDDYS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for DR REDDYS LABORATORIES
Please provide your vote to see the results

DR REDDYS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -19.009.2619.2274.142.18

What is the latest Core EBITDA Growth ratio of DR REDDYS LABORATORIES ?

The latest Core EBITDA Growth ratio of DR REDDYS LABORATORIES is -19.00 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-19.00
Mar20259.26
Mar202419.22
Mar202374.14
Mar20222.18

How is Core EBITDA Growth of DR REDDYS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2026 -19
Negative
Mar2025 9.26
-51.82
Mar2024 19.22
-74.08
Mar2023 74.14
3,300.92
Mar2022 2.18 -

Other Financial Ratios of DR REDDYS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DR REDDYS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR REDDYS LABORATORIES ₹97,826.8 Cr 0.2% -7.7% -7.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
MANKIND PHARMA ₹100,730.0 Cr -1.4% -3.7% -5.3% Stock Analytics


DR REDDYS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR REDDYS LABORATORIES

0.2%

-7.7%

-7.5%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses